CEGFebruary 24, 2026 at 2:50 PM UTCUtilities

CEG's Q4 Earnings Beat Masks Underlying Volatility and Policy Dependence

Read source article

What happened

Constellation Energy reported Q4 earnings of $2.3 per share, beating the Zacks Consensus Estimate of $2.2 per share. However, this represents a decline from $2.44 per share a year ago, signaling potential earnings pressure despite the headline beat. According to the DeepValue report, CEG's earnings are heavily reliant on policy credits like the 45U nuclear PTC, which contributed approximately $2,080 million to 2024 revenues. The current valuation at 33.3x P/E embeds significant optimism around AI-driven demand and Calpine integration, but near-term execution risks remain, including DOJ-mandated divestitures. This earnings update reinforces the report's view that investors should wait for clearer signs on divestiture execution and policy credit stability before committing capital.

Implication

The earnings beat, while positive, is overshadowed by the year-over-year decline, highlighting CEG's exposure to volatile power markets and policy credit fluctuations. With a P/E of 33.3x, the stock is pricing in perfection, yet near-term risks like DOJ divestitures and Crane restart delays could impact cash flows. The DeepValue report emphasizes that investment-grade status is crucial to avoid $2.4B in collateral calls, making earnings stability vital. Investors should focus on upcoming catalysts, such as divestiture announcements and PJM rule changes, rather than short-term earnings beats. Therefore, maintaining a cautious stance aligns with the report's recommendation to wait for observable execution milestones before investing.

Thesis delta

The earnings beat does not alter the core investment thesis; it underscores the earnings sensitivity to policy credits and market conditions highlighted in the report. However, the year-over-year decline may signal margin pressures that warrant monitoring, especially with integration costs from the Calpine acquisition. Overall, the WAIT rating remains appropriate as key catalysts have yet to materialize.

Confidence

High